trulicity tirzepatide The Weight Loss Showdown: Mounjaro vs. Tirzepatide cuts risk of diabetes

Reference to branded medications or other companies' products is for informational purposes only and does not constitute endorsement by those entities of MEDVi's services or compounded formulations

Under the new arrangement, consumers who are overweight and have prediabetes or who have had a stroke or other cardiovascular disease will be eligible, as will those who have obesity and diabetes or uncontrolled high blood pressure and severe obesity

Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, McMurdo ME, Mets T, Seal C, Wijers SL, Ceda GP, De VG, Donders G, Drey M, Greig C, Holmback U, Narici M, McPhee J, Poggiogalle E, Power D, Scafoglieri A, Schultz R, Sieber CC, Cederholm T

Sources: National Institute of Health Vitamin B12 deficiency .